Abstract:ABSTRACT We previously demonstrated that mutation of sarA in Staphylococcus aureus limits biofilm formation, cytotoxicity for osteoblasts and osteoclasts, and virulence in osteomyelitis, and that all of these phenotypes can be attributed to the increased production of extracellular proteases. Here we extend these studies to assess the individual importance of these proteases alone and in combination with each other using the methicillin-resistant USA300 strain LAC, the methicillin-susceptible USA200 strain UAMS-1, and isogenic sarA mutants that were also unable to produce aureolysin (Aur), staphopain A (ScpA), staphylococcal serine protease A (subsp.), staphopain B (SspB), and the staphylococcal serine protease-like proteins A-F (SplA-F). Biofilm formation was restored in LAC and UAMS-1 sarA mutants by subsequent mutation of aur and scpA , while mutation of aur had the greatest impact on cytotoxicity to mammalian cells, particularly with conditioned medium (CM) from the more cytotoxic strain LAC. However, SDS-PAGE and western blot analysis of CM confirmed that mutation of sspAB was also required to mimic the phenotype of sarA mutants unable to produce any extracellular proteases. Nevertheless, in a murine model of post-traumatic osteomyelitis, mutation of aur and scpA had the greatest impact on restoring the virulence of LAC and UAMS-1 sarA mutants, with concurrent mutation of sspAB and the spl operon having relatively little effect. These results demonstrate that the increased production of Aur and ScpA in combination with each other is a primary determinant of the reduced virulence of S. aureus sarA mutants in diverse clinical isolates including both methicillin-resistant and methicillin-susceptible strains. IMPORTANCE Previous work established that SarA plays a primary role in limiting the production of extracellular proteases to prevent them from limiting the abundance of S. aureus virulence factors. Eliminating the production of all 10 extracellular proteases in the methicillin-resistant strain LAC has also been shown to enhance virulence in a murine sepsis model, and this has been attributed to the specific proteases Aur and ScpA. The importance of this work lies in our demonstration that the increased production of these same proteases largely accounts for the decreased virulence of sarA mutants in a murine model of post-traumatic osteomyelitis not only in LAC but also in the methicillin-susceptible human osteomyelitis isolate UAMS-1. This confirms that sarA -mediated repression of Aur and ScpA production plays a critical role in the posttranslational regulation of S. aureus virulence factors in diverse clinical isolates and diverse forms of S. aureus infection.

SarA Family Proteins and Its Post-Translational Modification in Staphylococcus aureus

Structural and Function Analyses of the Global Regulatory Protein SarA from Staphylococcus Aureus.

Expression and Characteristics of the Staphylococcal Accessory Regulator of Virulence Factors for Staphylococcus Epidermidis

Crystal Structures of the Reduced, Sulfenic Acid, and Mixed Disulfide Forms of SarZ, a Redox Active Global Regulator in Staphylococcus aureus

Protein cysteine phosphorylation of SarA/MgrA family transcriptional regulators mediates bacterial virulence and antibiotic resistance

The Virulence Regulatory Systems TCRs and SarA in Staphylococcus aureus

Crystallographic studies of SarV, a global regulator from Staphylococcus aureus

Regulation of saeRS , agrA and sarA on sasX Expression in Staphylococcus aureus

SarA, a Global Regulator of Virulence Determinants inStaphylococcus aureus, Binds to a Conserved Motif Essential for sar-dependent Gene Regulation

SarZ is a Key Regulator of Biofilm Formation and Virulence in Staphylococcus Epidermidis.

A New Oxidative Sensing and Regulation Pathway Mediated by the Mgra Homologue Sarz in Staphylococcus Aureus

Presence and mRNA Expression of the sar Family Genes in Clinical and Non-clinical (Healthy Conjunctiva and Healthy Skin) Isolates of Staphylococcus epidermidis

Increased production of aureolysin and staphopain A is a primary determinant of the reduced virulence of Staphylococcus aureus sarA mutants in osteomyelitis

The Staphylococcus Aureus ArlRS Two-Component System Regulates Virulence Factor Expression Through MgrA.

The Staphylococcus Aureus Protein-Coding Gene Gdps Modulates Sars Expression Via Mrna-Mrna Interaction

The Global RegulonsarARegulates Β-Lactam Antibiotic Resistance in Methicillin-ResistantStaphylococcus Aureusin Vitro and in Endovascular Infections

Regulation of Staphylococcus aureus Virulence

Influence of Transcription Regulator SAUSA300_1968 on the Virulence Protein Secretion and Immune Evasion by Staphylococcus Aureus.

Baohuoside I inhibits virulence of multidrug-resistant Staphylococcus aureus by targeting the transcription Staphylococcus accessory regulator factor SarZ

The Role of Staphylococcus aureus YycFG in Gene Regulation, Biofilm Organization and Drug Resistance

Rewiring of the FtsH regulatory network by a single nucleotide change in saeS of Staphylococcus aureus